Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Cancer Science|April 29, 2022
Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional studyEiji Kozawa, Yoshihiro Nishida, Akira Kawai, et al.
BMC Surgery|January 25, 2025
Clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures: a retrospective study of 59 casesToru Hirozane, Tetsuya Sekita, Eisuke Kobayashi, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|November 19, 2025
Preoperative administration of denosumab is a feasible adjuvant option for the treatment of resectable giant cell tumor of bone in the spine: A multi-institutional study by the Japanese Musculoskeletal Oncology groupTakeshi Morii, Naofumi Asano, Robert Nakayama, et al.
Cancers|May 16, 2023
Clinical Outcome of Low-Grade Myofibroblastic Sarcoma in Japan: A Multicenter Study from the Japanese Musculoskeletal Oncology GroupMunehisa Kito, Keisuke Ae, Masanori Okamoto, et al.
Clinical Orthopaedics and Related Research|November 16, 2020
Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with LeiomyosarcomaYoshiyuki Suehara, Shinji Kohsaka, Takuo Hayashi, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|June 21, 2017
Factors associated with the decision of operative procedure for proximal femoral bone metastasis: Questionnaire survey to institutions participating the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology GroupNobuhito Araki, Hirokazu Chuman, Tomoya Matsunobu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 10, 2022
Dedifferentiated liposarcoma in the extremity and trunk wall: A multi-institutional study of 132 cases by the Japanese Musculoskeletal Oncology Group (JMOG)Takeshi Morii, Ukei Anazawa, Chiaki Sato, et al.
BMC Cancer|September 8, 2019
Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304Kazuhiro Tanaka, Junki Mizusawa, Norifumi Naka, et al.
BMC Cancer|March 8, 2023
Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanibMakoto Endo, Tomoko Kataoka, Toshifumi Fujiwara, et al.
World Journal of Surgical Oncology|August 12, 2018
Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304Kazuhiro Tanaka, Gakuto Ogawa, Junki Mizusawa, et al.
Pageof 9